ES532125A0 - Un procedimiento de preparacion de nuevas formas galenicas de n-(etil-1-pirrolidinil-2-)-metil-metoxi-2-sulfamoil-5-benzamida, utilizables por via oral - Google Patents

Un procedimiento de preparacion de nuevas formas galenicas de n-(etil-1-pirrolidinil-2-)-metil-metoxi-2-sulfamoil-5-benzamida, utilizables por via oral

Info

Publication number
ES532125A0
ES532125A0 ES532125A ES532125A ES532125A0 ES 532125 A0 ES532125 A0 ES 532125A0 ES 532125 A ES532125 A ES 532125A ES 532125 A ES532125 A ES 532125A ES 532125 A0 ES532125 A0 ES 532125A0
Authority
ES
Spain
Prior art keywords
pirrolidinil
sulfamoil
metoxi
etil
benzamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES532125A
Other languages
English (en)
Other versions
ES8502332A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe dEtudes Scientifiques et Industrielles de lIle de France SA
Original Assignee
Societe dEtudes Scientifiques et Industrielles de lIle de France SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe dEtudes Scientifiques et Industrielles de lIle de France SA filed Critical Societe dEtudes Scientifiques et Industrielles de lIle de France SA
Publication of ES532125A0 publication Critical patent/ES532125A0/es
Publication of ES8502332A1 publication Critical patent/ES8502332A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
ES532125A 1983-12-23 1984-05-03 Un procedimiento de preparacion de nuevas formas galenicas de n-(etil-1-pirrolidinil-2-)-metil-metoxi-2-sulfamoil-5-benzamida, utilizables por via oral Expired ES8502332A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8320635A FR2556964A1 (fr) 1983-12-23 1983-12-23 Nouvelles formes galeniques du sulpiride utilisables par voie orale

Publications (2)

Publication Number Publication Date
ES532125A0 true ES532125A0 (es) 1985-01-01
ES8502332A1 ES8502332A1 (es) 1985-01-01

Family

ID=9295477

Family Applications (1)

Application Number Title Priority Date Filing Date
ES532125A Expired ES8502332A1 (es) 1983-12-23 1984-05-03 Un procedimiento de preparacion de nuevas formas galenicas de n-(etil-1-pirrolidinil-2-)-metil-metoxi-2-sulfamoil-5-benzamida, utilizables por via oral

Country Status (38)

Country Link
EP (1) EP0147244A1 (es)
JP (1) JPS60139616A (es)
KR (1) KR910004570B1 (es)
AR (1) AR231398A1 (es)
AU (1) AU569516B2 (es)
BE (1) BE899331A (es)
BG (1) BG49707A3 (es)
CH (1) CH659386A5 (es)
CZ (1) CZ262984A3 (es)
DD (1) DD220782A5 (es)
DE (1) DE3412868A1 (es)
DK (1) DK165729C (es)
ES (1) ES8502332A1 (es)
FI (1) FI82603C (es)
FR (1) FR2556964A1 (es)
GB (1) GB2151920B (es)
GR (1) GR79584B (es)
HU (1) HU190924B (es)
IE (1) IE57164B1 (es)
IL (1) IL71470A (es)
IN (1) IN160415B (es)
IS (1) IS1364B6 (es)
IT (1) IT1177655B (es)
LU (1) LU85290A1 (es)
MA (1) MA20088A1 (es)
MX (1) MX7715E (es)
NO (1) NO169575C (es)
NZ (1) NZ207753A (es)
OA (1) OA07700A (es)
PH (1) PH21938A (es)
PL (1) PL144356B1 (es)
PT (1) PT78382B (es)
RO (1) RO89437A (es)
SU (1) SU1478993A3 (es)
YU (1) YU44762B (es)
ZA (1) ZA842573B (es)
ZM (1) ZM2084A1 (es)
ZW (1) ZW6084A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8414220D0 (en) * 1984-06-04 1984-07-11 Sterwin Ag Medicaments in unit dose form
DE3678643D1 (de) * 1985-08-16 1991-05-16 Procter & Gamble Partikel mit konstanter wirkstofffreisetzung.
US4853229A (en) * 1987-10-26 1989-08-01 Alza Corporation Method for adminstering tiny pills
JPH0791184B2 (ja) * 1988-03-31 1995-10-04 田辺製薬株式会社 放出制御型製剤およびその製法
GB8903328D0 (en) * 1989-02-14 1989-04-05 Ethical Pharma Ltd Nifedipine-containing pharmaceutical compositions and process for the preparation thereof
FR2762213B1 (fr) * 1997-04-18 1999-05-14 Synthelabo Composition pharmaceutique a retention gastrique

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3342826A (en) * 1964-01-13 1967-09-19 Ile De France Heterocyclic aminoalkyl benzamides
FR2313915A1 (fr) * 1976-01-26 1977-01-07 Corneille Gilbert Nouvelle forme galenique d'administration de la vincamine et de ses derives, son procede de preparation et medicaments comprenant cette nouvelle forme
US4285665A (en) * 1978-05-08 1981-08-25 Johnson, Matthey & Co., Limited Engines
FR2453639A1 (fr) * 1979-04-09 1980-11-07 Sanofi Sa Composition medicamenteuse a liberation programmee immediate-retard a base de naftidrofuryl
FR2453642A1 (fr) * 1979-04-12 1980-11-07 Sanofi Sa Compositions therapeutiques a usage oral et a liberation programmee du methanesulfonate de dihydroergotoxine
FR2454804B1 (fr) * 1979-04-26 1986-11-21 Sanofi Sa Medicament a base de dihydroergotoxine et son procede de preparation
FR2470599A1 (fr) * 1979-12-07 1981-06-12 Panoz Donald Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
SE8003805L (sv) * 1980-05-21 1981-11-22 Haessle Ab En farmaceutisk beredning med forbettrade utlosningsegenskap
JPS5753326A (en) * 1980-09-17 1982-03-30 Dainippon Printing Co Ltd Manufacture of biaxially stretching blow molded vessel of saturated polyester
FR2492661A1 (fr) * 1980-10-28 1982-04-30 Laruelle Claude Nouvelle forme galenique d'administration du metoclopramide, son procede de preparation et medicament comprenant cette nouvelle forme
FR2494112B1 (es) * 1980-11-19 1986-01-10 Laruelle Claude
FR2534139B1 (fr) * 1982-10-07 1986-08-29 Laruelle Claude Nouvelle forme galenique du sulpiride, son procede de preparation et medicament comprenant cette nouvelle forme

Also Published As

Publication number Publication date
BE899331A (fr) 1984-10-05
IS2900A7 (is) 1984-11-14
IE840817L (en) 1985-06-23
IT1177655B (it) 1987-08-26
CZ262984A3 (en) 1995-07-12
YU64084A (en) 1988-02-29
DK180784D0 (da) 1984-04-06
IL71470A0 (en) 1984-07-31
MX7715E (es) 1990-10-09
GB8408978D0 (en) 1984-05-16
GB2151920A (en) 1985-07-31
FI82603C (fi) 1991-04-10
HU190924B (en) 1986-12-28
FI841376A (fi) 1985-06-24
IS1364B6 (is) 1989-05-25
ES8502332A1 (es) 1985-01-01
IT8448001A0 (it) 1984-04-06
NZ207753A (en) 1987-08-31
DE3412868A1 (de) 1985-07-11
DK165729B (da) 1993-01-11
AU2890484A (en) 1985-06-27
MA20088A1 (fr) 1984-12-31
IE57164B1 (en) 1992-05-20
ZW6084A1 (en) 1984-08-08
GR79584B (es) 1984-10-30
PH21938A (en) 1988-04-15
SU1478993A3 (ru) 1989-05-07
KR910004570B1 (ko) 1991-07-06
KR850005065A (ko) 1985-08-21
IL71470A (en) 1987-07-31
EP0147244A1 (fr) 1985-07-03
LU85290A1 (fr) 1984-10-26
IT8448001A1 (it) 1985-10-06
NO169575B (no) 1992-04-06
JPH0461848B2 (es) 1992-10-02
JPS60139616A (ja) 1985-07-24
DD220782A5 (de) 1985-04-10
ZM2084A1 (en) 1984-12-21
OA07700A (fr) 1985-08-30
DK165729C (da) 1993-06-07
CH659386A5 (fr) 1987-01-30
NO841367L (no) 1985-06-24
AU569516B2 (en) 1988-02-04
DK180784A (da) 1985-06-24
HUT35518A (en) 1985-07-29
FI841376A0 (fi) 1984-04-06
NO169575C (no) 1992-07-15
PT78382B (fr) 1986-05-28
ZA842573B (en) 1984-11-28
PT78382A (fr) 1984-05-01
RO89437A (ro) 1986-06-30
IN160415B (es) 1987-07-11
PL247098A1 (en) 1985-07-02
YU44762B (en) 1991-02-28
BG49707A3 (en) 1992-01-15
GB2151920B (en) 1987-09-23
FR2556964A1 (fr) 1985-06-28
PL144356B1 (en) 1988-05-31
AR231398A1 (es) 1984-11-30
FI82603B (fi) 1990-12-31

Similar Documents

Publication Publication Date Title
ES524029A0 (es) Un procedimiento para la preparacion de nuevas n-(heterociclil biciclo)-4-piperidinaminas.
ES537293A0 (es) Un procedimiento para la preparacion de derivados de amino alquilentio-alquilentiofosfonatos.
ES533097A0 (es) Un procedimiento para la preparacion de nuevos derivados del amino-metil-oxooxazolidinil-benzeno.
ES521435A0 (es) Un procedimiento para la preparacion de quinolizidinil benzamidas.
ES538336A0 (es) Un procedimiento para la preparacion de derivados de indol.
ES522451A0 (es) Un procedimiento para la preparacion de una urea.
ES534825A0 (es) Un procedimiento para la preparacion de nuevos antagonistas de leucotrieno.
ES536525A0 (es) Un procedimiento para la preparacion de derivados de fenotiazinas.
ES511079A0 (es) Un procedimiento para la preparacion de una n-(2-pirimidinil) piperazinilalquilazaespiroalcanodiona.
ES550879A0 (es) Procedimiento para la preparacion de 4h-3,1-benzoxazin-4-- onas y compuestos relacionados
ES517988A0 (es) Procedimiento para la preparacion de nuevas n-(4-indolil-piperidino-alcohil-bencimidazolonas sustituidas.
ES544527A0 (es) Un procedimiento para la preparacion de nuevas benzamidas sustituidas.
ES545162A0 (es) Un procedimiento para la preparacion de derivados de aminofenol.
ES537023A0 (es) Un procedimiento para la preparacion de nuevos antagonistas de los leucotrienos.
ES532125A0 (es) Un procedimiento de preparacion de nuevas formas galenicas de n-(etil-1-pirrolidinil-2-)-metil-metoxi-2-sulfamoil-5-benzamida, utilizables por via oral
ES523677A0 (es) Un procedimiento para la preparacion de derivados de urea.
ES534642A0 (es) Un procedimiento para la preparacion de nuevos derivados de carbaciclina.
ES543776A0 (es) Un procedimiento para la preparacion de nuevos 16-fluor-16, 17-dideshidro prostanoides
AR214330A1 (es) Procedimiento para la preparacion de n-(1'-alil-2'-pirrolidilmetil)-2,3-dimetoxi-5-sulfamoilbenzamida
ES535966A0 (es) Un procedimiento para la preparacion de nuevos derivados de 4,5-dihidro-2h-piridazin-3-ona.
ES536687A0 (es) Un procedimiento para la preparacion de nuevos derivados de 2-azaciclos alquiltiopenen.
DK34888A (da) Fremgangsmaade til fremstilling af n,n-(dibenzohexatrienylen)urinstoffer
ES537359A0 (es) Un procedimiento para la preparacion de nuevos derivados de feniletanamina.
ES521773A0 (es) Un procedimiento para la preparacion de nuevas benzamidas.
ES543366A0 (es) Procedimiento para la preparacion de derivados de feniletilamina.